Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Changes Induced by Inflammatory-Activated Immune Cell Microenvironment in the Paracrine Profile of MSC.

Gornostaeva AN., Buravkova LB.

Laboratory Study, published in Bull Exp Biol Med (2023) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Bull Exp Biol Med (2023)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
36894814
DOI
10.1007/s10517-023-05745-x

Abstract (original English)

We studied the influence of activated innate and adaptive immune cells on the production of growth factors by human adipose tissue multipotent mesenchymal stromal cells (MSC). MSC showed immunosuppressive properties in vitro: decreased activation and proliferation of stimulated immune cells. T-cell interaction with MSC resulted with increased secretion of EGF, PDGF-AB/BB, FGF-2, and VEGF growth factors. Co-culturing with natural killer cells also stimulated TGFα production. The intensity of the effect varied depending on the type of immune cells. Natural killer caused a more significant increase in PDGF-AB/BB and FGF-2 secretion, while VEGF secretion increased stronger after co-culturing with T cells. The obtained data indicate the possibility of increasing reparative potential of MSC under the influence of inflammatory microenvironment.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansBecaplerminCell ProliferationCellular MicroenvironmentCoculture TechniquesFibroblast Growth Factor 2Vascular Endothelial Growth Factor AMesenchymal Stem CellsKiller Cells, NaturalParacrine Communication

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.